Key statistics
On Friday, Satellos Bioscience Inc (0ITA:DEU) closed at 0.318, 89.29% above the 52 week low of 0.168 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.29 |
---|---|
High | 0.332 |
Low | 0.29 |
Bid | 0.312 |
Offer | 0.34 |
Previous close | 0.316 |
Average volume | 1.10k |
---|---|
Shares outstanding | 112.86m |
Free float | 98.80m |
P/E (TTM) | -- |
Market cap | 55.86m CAD |
EPS (TTM) | -0.2044 CAD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247
- Satellos Announces Participation in September 2024 Investor Conferences
- Satellos Announces Acceptance of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247
- Satellos Announces Q2 2024 Financial Results and Updated Canine Data
- Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
- Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247
- Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy (“DMD”)
- Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
More ▼